167 related articles for article (PubMed ID: 27364545)
1. Steroid hormone receptors and prostate cancer: role of structural dynamics in therapeutic targeting.
Kumar R
Asian J Androl; 2016; 18(5):682-6. PubMed ID: 27364545
[TBL] [Abstract][Full Text] [Related]
2. A sting in the tail: the N-terminal domain of the androgen receptor as a drug target.
Monaghan AE; McEwan IJ
Asian J Androl; 2016; 18(5):687-94. PubMed ID: 27212126
[TBL] [Abstract][Full Text] [Related]
3. Binding-folding induced regulation of AF1 transactivation domain of the glucocorticoid receptor by a cofactor that binds to its DNA binding domain.
Garza AS; Khan SH; Moure CM; Edwards DP; Kumar R
PLoS One; 2011; 6(10):e25875. PubMed ID: 22003412
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional relationships of the steroid hormone receptors' N-terminal transactivation domain.
Kumar R; Litwack G
Steroids; 2009 Nov; 74(12):877-83. PubMed ID: 19666041
[TBL] [Abstract][Full Text] [Related]
5. Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor.
Sadar MD
Expert Opin Drug Discov; 2020 May; 15(5):551-560. PubMed ID: 32100577
[No Abstract] [Full Text] [Related]
6. Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges.
Simons SS; Edwards DP; Kumar R
Mol Endocrinol; 2014 Feb; 28(2):173-82. PubMed ID: 24284822
[TBL] [Abstract][Full Text] [Related]
7. Role of Phosphorylation in the Modulation of the Glucocorticoid Receptor's Intrinsically Disordered Domain.
Kumar R; Thompson EB
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30862072
[TBL] [Abstract][Full Text] [Related]
8. TBP binding-induced folding of the glucocorticoid receptor AF1 domain facilitates its interaction with steroid receptor coactivator-1.
Khan SH; Ling J; Kumar R
PLoS One; 2011; 6(7):e21939. PubMed ID: 21760925
[TBL] [Abstract][Full Text] [Related]
9. Folding of the glucocorticoid receptor N-terminal transactivation function: dynamics and regulation.
Kumar R; Thompson EB
Mol Cell Endocrinol; 2012 Jan; 348(2):450-6. PubMed ID: 21501657
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
Shafi AA; Yen AE; Weigel NL
Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
[TBL] [Abstract][Full Text] [Related]
11. Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer.
Ray MR; Wafa LA; Cheng H; Snoek R; Fazli L; Gleave M; Rennie PS
Int J Cancer; 2006 Mar; 118(5):1108-19. PubMed ID: 16161052
[TBL] [Abstract][Full Text] [Related]
12. The human androgen receptor AF1 transactivation domain: interactions with transcription factor IIF and molten-globule-like structural characteristics.
Lavery DN; McEwan IJ
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1054-7. PubMed ID: 17073749
[TBL] [Abstract][Full Text] [Related]
13. Beyond androgen deprivation: ancillary integrative strategies for targeting the androgen receptor addiction of prostate cancer.
McCarty MF; Hejazi J; Rastmanesh R
Integr Cancer Ther; 2014 Sep; 13(5):386-95. PubMed ID: 24867960
[TBL] [Abstract][Full Text] [Related]
14. Influence of flanking sequences on signaling between the activation function AF1 and DNA-binding domain of the glucocorticoid receptor.
Kumar R; Thompson EB
Arch Biochem Biophys; 2010 Apr; 496(2):140-5. PubMed ID: 20188692
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic disorder in the androgen receptor: identification, characterisation and drugability.
McEwan IJ
Mol Biosyst; 2012 Jan; 8(1):82-90. PubMed ID: 21822504
[TBL] [Abstract][Full Text] [Related]
16. Trehalose induces functionally active conformation in the intrinsically disordered N-terminal domain of glucocorticoid receptor.
Khan SH; Jasuja R; Kumar R
J Biomol Struct Dyn; 2017 Aug; 35(10):2248-2256. PubMed ID: 27425791
[TBL] [Abstract][Full Text] [Related]
17. Androgen ablation elicits PP1-dependence for AR stabilization and transactivation in prostate cancer.
Liu X; Han W; Gulla S; Simon NI; Gao Y; Liu J; Wang L; Yang H; Zhang X; Chen S
Prostate; 2016 May; 76(7):649-61. PubMed ID: 26847655
[TBL] [Abstract][Full Text] [Related]
18. Prostate-associated gene 4 (PAGE4), an intrinsically disordered cancer/testis antigen, is a novel therapeutic target for prostate cancer.
Kulkarni P; Dunker AK; Weninger K; Orban J
Asian J Androl; 2016; 18(5):695-703. PubMed ID: 27270343
[TBL] [Abstract][Full Text] [Related]
19. Variable steroid receptor responses: Intrinsically disordered AF1 is the key.
Simons SS; Kumar R
Mol Cell Endocrinol; 2013 Aug; 376(1-2):81-4. PubMed ID: 23792173
[TBL] [Abstract][Full Text] [Related]
20. Poly (A) Binding Protein Cytoplasmic 1 Is a Novel Co-Regulator of the Androgen Receptor.
Eisermann K; Dar JA; Dong J; Wang D; Masoodi KZ; Wang Z
PLoS One; 2015; 10(7):e0128495. PubMed ID: 26176602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
